AndrewJohnBarkmeierMD
Ophthalmology • Rochester, MNRetinal Disease
Associate Professor of Ophthalmology, Mayo Medical School
Dr. Barkmeier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Baylor College of MedicineFellowship, Surgical Retina and Vitreous, 2008 - 2010
SSM Health/Saint Louis University School of MedicineResidency, Ophthalmology, 2005 - 2008
Medical College of WisconsinClass of 2004
Certifications & Licensure
MN State Medical License 2010 - 2025
TX State Medical License 2008 - 2011
IL State Medical License 2004 - 2005- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Achievement Award American Academy of Ophthalmology, 2017
- Honor Award American Society of Retina Specialists, 2016
- Mayo Clinic Ophthalmology Teacher of the Year Mayo Fellows' Association, 2013
Publications & Presentations
PubMed
- 1003 citationsAflibercept, bevacizumab, or ranibizumab for diabetic macular edema.John A. Wells, Adam R. Glassman, Allison R. Ayala, Lee M. Jampol, Lloyd Paul Aiello
The New England Journal of Medicine. 2015-03-26 - 245 citationsBaseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular DegenerationGui-Shuang Ying, Jiayan Huang, Maureen G. Maguire, Glenn J. Jaffe, Juan E. Grunwald
Ophthalmology. 2013-01-01 - 261 citationsCultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.Erica J. Carrier, Christopher S. Kearn, Andrew J. Barkmeier, Nicole M. Breese, Wenqi Yang
Molecular Pharmacology. 2004-04-01
Press Mentions
Research Promises Better Diabetic Retinopathy ManagementAugust 16th, 2024
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
- Member
- Retina SocietyMember
- Association for Research in Vision and OphthalmologyMember
- Association of University Professors of OphthalmologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
